Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

FDA Commissioner Makary sits down for a conversation with the newly appointed director of the Center for Biologics Evaluation and Research (CBER) Dr. Vinayak “Vinay” Kashyap Prasad and Sanjula Jain-Nagpal, Associate Director of Policy & Research Strategy, Office of the Commissioner (OC). The trio talks about the current and... show more

U.S. FDA

591,117 subscribers

462,670 Aufrufe • vor 1 Jahr •via X (Twitter)

Gesundheit & Wellness Nachrichten & Politik Wissenschaft & Technologie

Anya Rossi• Live Now

Private livecam show

10 Kommentare

Profilbild von Prognostic Chats

Prognostic Chatsvor 1 Jahr

“We aren’t sure about kids” or “healthcare workers who’ve just had Covid if they need a booster”. @VPrasadMDMPH actually said that out loud, in 2025, as if the evidence isn’t crystal clear by now of how Covid affects children or healthcare workers. He should read some studies.

Profilbild von JMIR Publications

JMIR Publicationsvor 1 Jahr

#CallForPapers - Be a founding author in JMIR XR and Spatial Computing! Share your research in our debut theme issue: “First Look: Early Research, Viewpoints, and Experiences with #AppleVisionPro in Health Care Settings.” ✅ Waived fees!

Profilbild von Wafik S. El-Deiry, MD, PhD, FACP

Wafik S. El-Deiry, MD, PhD, FACPvor 1 Jahr

Good to hear Vinay state publicly RCTs may not be appropriate pre-approval for rare diseases. RCTs are similarly challenging in precision oncology (the future of oncology). Real-world control arms are useful. @Dr_R_Kurzrock @VivekSubbiah @VPrasadMDMPH

Profilbild von Anthony

Anthonyvor 1 Jahr

Love to see this administration opening it's opinions up to the public. Glass box >>> black box!

Profilbild von MJD

MJDvor 1 Jahr

This is a useful early look towards agency thinking,allowing narrative control on priorities/view points. The comments on FDA transparency, American public focus, innovation and solidified philosophical goal posts should resonate with individuals, industry + investors alike.Tx

Profilbild von Ex_Citizen_BuckTweet 🌸

Ex_Citizen_BuckTweet 🌸vor 1 Jahr

Do regular chats so people know what's happening. Why not?

Profilbild von patateryx

patateryxvor 1 Jahr

Fantastic conversation. Been following Marty & Vinay’s work for years now. In regards to the topic of inviting “stakeholders” to the campus and opening up the conversation, please include discussions of psychedelics and how the FDA can evaluate the strong evidence & move forward

Profilbild von Jerry

Jerryvor 1 Jahr

@MartyMakary the guy who says regulatory flexibility and accelerating timelines for approval appoints a guy who doesn’t believe in surrogate endpoints in lieu of maturing OS data. We can’t trust anything you say anymore

Profilbild von Thomas Jones

Thomas Jonesvor 1 Jahr

Two great physicians who have brought a common sense, balanced and scientifically nuanced approach to the FDA.

Profilbild von Nick zheng

Nick zhengvor 1 Jahr

from blackbox to glassbox, FDA is going to win public support and trust, and serve American citizens better. One suggestion: please publish CRL letters to tell every one why a drug is not approved.

Ähnliche Videos

🚨WOW! The FDA’s new and promising initiative - regulatory flexibilities for Cell and Gene therapies, is a direct result of the recent Cell & Gene Therapy Roundtable 🧵👇 that was hosted 6 months ago by FDA commissioner Dr. Marty Makary and the director of the FDA’s Center for Biologics Evaluation and Research (CBER) Vinay Prasad MD MPH, in which top industry leaders and scientists shared their views about how to accelerate the R&D process and innovation in the 🇺🇸 BioTech and Pharma ecosystem. It is great to see that this important meeting bore fruit and helped not only to shape the future of the American BioTech ecosystem for years to come but also provided huge hope for patients with genetic diseases worldwide!

🚨WOW! The FDA’s new and promising initiative - regulatory flexibilities for Cell and Gene therapies, is a direct result of the recent Cell & Gene Therapy Roundtable 🧵👇 that was hosted 6 months ago by FDA commissioner Dr. Marty Makary and the director of the FDA’s Center for Biologics Evaluation and Research (CBER) Vinay Prasad MD MPH, in which top industry leaders and scientists shared their views about how to accelerate the R&D process and innovation in the 🇺🇸 BioTech and Pharma ecosystem. It is great to see that this important meeting bore fruit and helped not only to shape the future of the American BioTech ecosystem for years to come but also provided huge hope for patients with genetic diseases worldwide!

Yair Einhorn

25,260 Aufrufe • vor 7 Monaten

FDA Commissioner Dr. Marty Makary talks about promising treatments in the pipeline and the innovations and breakthroughs he’d like to see in the future.

FDA Commissioner Dr. Marty Makary talks about promising treatments in the pipeline and the innovations and breakthroughs he’d like to see in the future.

U.S. FDA

145,812 Aufrufe • vor 1 Jahr

In this FDA Direct, Dr. Marty Makary welcomes FDA’s new Director of the Center for Drug Evaluation and Research, Dr. George Tidmarsh. Dr. Tidmarsh brings more than 30 years of experience spanning biotechnology, clinical medicine, and regulatory science, and will lead FDA’s efforts to ensure safe, effective drugs reach the American people.

In this FDA Direct, Dr. Marty Makary welcomes FDA’s new Director of the Center for Drug Evaluation and Research, Dr. George Tidmarsh. Dr. Tidmarsh brings more than 30 years of experience spanning biotechnology, clinical medicine, and regulatory science, and will lead FDA’s efforts to ensure safe, effective drugs reach the American people.

U.S. FDA

28,366 Aufrufe • vor 1 Jahr

Acting CDC Director Dr. Jay Bhattacharya on potential ouster of FDA Commissioner: "You'd have to ask the president... Marty Makary is an absolutely amazing scholar, an absolutely amazing surgeon, an absolutely amazing FDA Commissioner, and a good friend of mine."

Sensitive content

Acting CDC Director Dr. Jay Bhattacharya on potential ouster of FDA Commissioner: "You'd have to ask the president... Marty Makary is an absolutely amazing scholar, an absolutely amazing surgeon, an absolutely amazing FDA Commissioner, and a good friend of mine."

State of the Union

58,230 Aufrufe • vor 3 Monaten

Former FDA commissioner Dr. Scott Gottlieb on President Trump's pick for the director of Centers for Disease Control and Prevention, Dr. Susan Monarez:

Former FDA commissioner Dr. Scott Gottlieb on President Trump's pick for the director of Centers for Disease Control and Prevention, Dr. Susan Monarez:

Face The Nation

44,297 Aufrufe • vor 1 Jahr

USDA Dismisses Claims That Pro-Science FDA Official Was Ousted Over Political Pressure At a Dept. of Agriculture press briefing, concerns were raised about the abrupt departure of Dr. Vinay Prasad, former Director of the FDA’s Center for Drug Evaluation and Research. Vinay Prasad MD MPH was praised for restoring integrity to drug and vaccine reviews and pushing back on Big Pharma influence. Reports claim pressure from political operatives tied to President Donald J. Trump, including Susie Wiles and Laura Loomer, played a role in his removal. FDA Commissioner Marty Makary MD, MPH denied those claims, stating Prasad resigned voluntarily after seeing media headlines and not wanting to be a distraction. But many remain unconvinced. With billions on the line for pharmaceutical giants, some argue Prasad was forced out for refusing to play along. The concern now is that he will be replaced with someone who will rubber-stamp every new drug and vaccine without question. LindellTV Reporter: Alison Steinberg

USDA Dismisses Claims That Pro-Science FDA Official Was Ousted Over Political Pressure At a Dept. of Agriculture press briefing, concerns were raised about the abrupt departure of Dr. Vinay Prasad, former Director of the FDA’s Center for Drug Evaluation and Research. Vinay Prasad MD MPH was praised for restoring integrity to drug and vaccine reviews and pushing back on Big Pharma influence. Reports claim pressure from political operatives tied to President Donald J. Trump, including Susie Wiles and Laura Loomer, played a role in his removal. FDA Commissioner Marty Makary MD, MPH denied those claims, stating Prasad resigned voluntarily after seeing media headlines and not wanting to be a distraction. But many remain unconvinced. With billions on the line for pharmaceutical giants, some argue Prasad was forced out for refusing to play along. The concern now is that he will be replaced with someone who will rubber-stamp every new drug and vaccine without question. LindellTV Reporter: Alison Steinberg

LindellTV

45,320 Aufrufe • vor 1 Jahr

Bombshell Video: FDA Commissioner Dr. Marty Makary Just Exposed the Fact That Fauci Paid to Create the Wuhan COVID-19 Virus Responsible for Killing 20 Million People and That the NIH Is Still Trying to Fund Gain of Function Research

Bombshell Video: FDA Commissioner Dr. Marty Makary Just Exposed the Fact That Fauci Paid to Create the Wuhan COVID-19 Virus Responsible for Killing 20 Million People and That the NIH Is Still Trying to Fund Gain of Function Research

Alex Jones

94,850 Aufrufe • vor 1 Jahr

Welcome FDA Commissioner Dr. Martin Makary and NIH Director Dr. Jay Bhattacharya. Let’s restore HHS health agencies to their rich tradition of gold-standard, evidence-based science to tackle the chronic disease epidemic and Make America Healthy Again. The revolution begins today!

Welcome FDA Commissioner Dr. Martin Makary and NIH Director Dr. Jay Bhattacharya. Let’s restore HHS health agencies to their rich tradition of gold-standard, evidence-based science to tackle the chronic disease epidemic and Make America Healthy Again. The revolution begins today!

Secretary Kennedy

1,373,263 Aufrufe • vor 1 Jahr

FDA Commissioner Dr. Marty Makary MD, MPH tells Jillian Michaels on NewsNation’s #OnBalance that the agency needs to "listen to doctors" and expand its research on psychedelic drugs, calling it a top priority for the Trump administration. MORE:

FDA Commissioner Dr. Marty Makary MD, MPH tells Jillian Michaels on NewsNation’s #OnBalance that the agency needs to "listen to doctors" and expand its research on psychedelic drugs, calling it a top priority for the Trump administration. MORE:

NewsNation

42,816 Aufrufe • vor 1 Jahr

Amazing, a former FDA associate commissioner Peter J. Pitts affirmed that the mechanism of action in the approved label confirms the science of Anktiva, by the FDA itself. Jay Bhattacharya agrees with Dr. Pitts and highlights the new path just released by Dr. Marty Makary of the “Plausible Mechanism of Action” to expedite and accelerate access to the American public. Two senior thoughtful members of the panel, a former FDA senior official and the present NIH/CDC director now affirm that the plausible mechanism of action is the path to rapid access. This is what we have been presenting to the FDA for the past 6 months to desperately allow the 13,000+ requests from Americans to access Anktiva via this pathway. A groundswell of patients desperate for this to happen is growing and I am pleased that Christopher C. Cuomo promised that this conversation will continue… as it must.

Amazing, a former FDA associate commissioner Peter J. Pitts affirmed that the mechanism of action in the approved label confirms the science of Anktiva, by the FDA itself. Jay Bhattacharya agrees with Dr. Pitts and highlights the new path just released by Dr. Marty Makary of the “Plausible Mechanism of Action” to expedite and accelerate access to the American public. Two senior thoughtful members of the panel, a former FDA senior official and the present NIH/CDC director now affirm that the plausible mechanism of action is the path to rapid access. This is what we have been presenting to the FDA for the past 6 months to desperately allow the 13,000+ requests from Americans to access Anktiva via this pathway. A groundswell of patients desperate for this to happen is growing and I am pleased that Christopher C. Cuomo promised that this conversation will continue… as it must.

Dr. Pat Soon-Shiong

825,658 Aufrufe • vor 5 Monaten

FDA Commissioner Dr. Marty Makary joined President Donald J. Trump and Secretary Kennedy at the MAHA Commission event this afternoon.

FDA Commissioner Dr. Marty Makary joined President Donald J. Trump and Secretary Kennedy at the MAHA Commission event this afternoon.

U.S. FDA

30,175 Aufrufe • vor 1 Jahr

#NDTVProfitExclusive | Does a meal out with friends ever turn into an FDA inspection for Commissioner Tukaram Mundhe (Tukaram Mundhe)? The FDA Commissioner recalls a time when the personal and professional intersected, in conversation with Nimitt Dixit

#NDTVProfitExclusive | Does a meal out with friends ever turn into an FDA inspection for Commissioner Tukaram Mundhe (Tukaram Mundhe)? The FDA Commissioner recalls a time when the personal and professional intersected, in conversation with Nimitt Dixit

NDTV Profit

34,186 Aufrufe • vor 1 Monat

“The scientific evaluation needs to be independent…” FDA Commissioner Marty Makary MD, MPH announces MAJOR new policy aimed at limiting conflicts of interest. Hear the full interview on SiriusXM Triumph channel 111 at 6pmET. Watch below:

“The scientific evaluation needs to be independent…” FDA Commissioner Marty Makary MD, MPH announces MAJOR new policy aimed at limiting conflicts of interest. Hear the full interview on SiriusXM Triumph channel 111 at 6pmET. Watch below:

The Megyn Kelly Show

10,213 Aufrufe • vor 1 Jahr

All-In Interview: FDA Commissioner Dr. Marty Makary david friedberg sits down with Dr. Marty Makary for a comprehensive convo on his overhaul of the FDA: -- Safely accelerating clinical trials -- US vs China in biotech -- Fixing the Food Pyramid -- Rethinking vaccines with common sense -- Cutting drug prices -- Power of AI in healthcare (0:00) Friedberg intros FDA Commissioner Marty Makary (3:21) Inside the 40+ major FDA reforms in 10 months (7:51) The China Race: Winning back biotech leadership (13:14) Accelerating drug approvals safely, how to cut down on clinical trial timelines (33:13) Reshaping the failed Food Pyramid (41:29) GLP-1s and America’s Obesity Epidemic (49:54) Rethinking vaccines from first principles (59:40) Lowering drug prices, the power of AI for healthcare (1:18:57) What causes autism?

All-In Interview: FDA Commissioner Dr. Marty Makary david friedberg sits down with Dr. Marty Makary for a comprehensive convo on his overhaul of the FDA: -- Safely accelerating clinical trials -- US vs China in biotech -- Fixing the Food Pyramid -- Rethinking vaccines with common sense -- Cutting drug prices -- Power of AI in healthcare (0:00) Friedberg intros FDA Commissioner Marty Makary (3:21) Inside the 40+ major FDA reforms in 10 months (7:51) The China Race: Winning back biotech leadership (13:14) Accelerating drug approvals safely, how to cut down on clinical trial timelines (33:13) Reshaping the failed Food Pyramid (41:29) GLP-1s and America’s Obesity Epidemic (49:54) Rethinking vaccines from first principles (59:40) Lowering drug prices, the power of AI for healthcare (1:18:57) What causes autism?

The All-In Podcast

152,288 Aufrufe • vor 7 Monaten

FDA Commissioner Dr. Marty Makary told Miranda Devine on the latest episode of "Pod Force One" that there will be new powerful treatments for certain types of cancer and neurodegenerative disorders during the Trump administration. Subscribe here:

FDA Commissioner Dr. Marty Makary told Miranda Devine on the latest episode of "Pod Force One" that there will be new powerful treatments for certain types of cancer and neurodegenerative disorders during the Trump administration. Subscribe here:

New York Post

24,921 Aufrufe • vor 8 Monaten

ALL mRNA COVID VACCINES RECEIVE UPDATED "EXTREMELY HIGH" RISK MYOCARDITIS & LONG-TERM HEART DAMAGE WARNING LABELS. The U.S. Food and Drug Administration (FDA) under the Trump administration has formally updated the safety labeling on all mRNA COVID-19 vaccines to reflect what many Americans have been warning about for years: a disturbingly high risk of myocarditis—particularly in young men—and the possibility of long-term, irreversible heart damage. The revised warnings apply to both Pfizer’s Comirnaty and Moderna’s Spikevax vaccines and follow months of mounting pressure over transparency and accountability regarding the true risks of these experimental injections. The update stems from new studies and data showing persistent cardiac abnormalities months after vaccination—especially among males aged 12 to 24. During a presentation of the new FDA safety data on Tuesday, Dr. Vinay Prasad, Director, Center for Biologics Evaluation & Research Chief Medical and Scientific Officer, walked the public through the harrowing evidence behind the label change. 1/37,000 risk of myocarditis/pericarditis in men 12-24 with likely irreversible injury to heart muscle itself. The Biden administration tried to downplay these known risks, likely causing harm to the public by preventing true informed consent. Link to full presentation video of the new FDA safety data from Dr. Vinay Prasad:

ALL mRNA COVID VACCINES RECEIVE UPDATED "EXTREMELY HIGH" RISK MYOCARDITIS & LONG-TERM HEART DAMAGE WARNING LABELS. The U.S. Food and Drug Administration (FDA) under the Trump administration has formally updated the safety labeling on all mRNA COVID-19 vaccines to reflect what many Americans have been warning about for years: a disturbingly high risk of myocarditis—particularly in young men—and the possibility of long-term, irreversible heart damage. The revised warnings apply to both Pfizer’s Comirnaty and Moderna’s Spikevax vaccines and follow months of mounting pressure over transparency and accountability regarding the true risks of these experimental injections. The update stems from new studies and data showing persistent cardiac abnormalities months after vaccination—especially among males aged 12 to 24. During a presentation of the new FDA safety data on Tuesday, Dr. Vinay Prasad, Director, Center for Biologics Evaluation & Research Chief Medical and Scientific Officer, walked the public through the harrowing evidence behind the label change. 1/37,000 risk of myocarditis/pericarditis in men 12-24 with likely irreversible injury to heart muscle itself. The Biden administration tried to downplay these known risks, likely causing harm to the public by preventing true informed consent. Link to full presentation video of the new FDA safety data from Dr. Vinay Prasad:

The SCIF

24,591 Aufrufe • vor 1 Jahr